BAKER BROS. ADVISORS LP - Significant Ownership

Signature - Title
Alexandra Toohey - Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BAKER BROS. ADVISORS LP.

Significant Ownership of BAKER BROS. ADVISORS LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KALA KALA BIO, Inc. Common Stock, $0.001 par value per share 19.7% $8.35M 1.2M Baker Bros. Advisors LP Dec 29, 2024
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 17.1% $124M 23.5M Baker Bros. Advisors LP Mar 27, 2025
SERA Sera Prognostics, Inc. Class A Common Stock, $0.0001 par value per share 16.1% $22.2M 5.5M Baker Bros. Advisors LP Feb 12, 2025
REPL Replimune Group, Inc. Common Stock, $0.001 par value per share 14.3% $134M 11M Baker Bros. Advisors LP Mar 7, 2025
CELC Celcuity Inc. Common Stock, par value $0.001 per share 11.3% $42.7M 4.26M Baker Bros. Advisors LP Mar 31, 2025
CADL Candel Therapeutics, Inc. Common Stock, par value $0.01 per share 6.8% $24.1M 2.98M Baker Bros. Advisors LP Dec 31, 2024
IMTX Immatics N.V. Ordinary Shares, nominal value (euro)0.01 per share 6% $33.1M 7.28M Baker Bros. Advisors LP Dec 31, 2024
BMEA Biomea Fusion, Inc. Common Stock, par value $0.0001 per share 4% $3.57M 1.45M Baker Bros. Advisors LP Dec 31, 2024

Schedules 13D/G Reported by BAKER BROS. ADVISORS LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.